ShuYu Civilian Pharmacy Balance Sheet Health
Financial Health criteria checks 2/6
ShuYu Civilian Pharmacy has a total shareholder equity of CN¥2.3B and total debt of CN¥3.6B, which brings its debt-to-equity ratio to 157.8%. Its total assets and total liabilities are CN¥9.3B and CN¥7.0B respectively. ShuYu Civilian Pharmacy's EBIT is CN¥87.4M making its interest coverage ratio 0.7. It has cash and short-term investments of CN¥1.3B.
Key information
157.8%
Debt to equity ratio
CN¥3.64b
Debt
| Interest coverage ratio | 0.7x |
| Cash | CN¥1.34b |
| Equity | CN¥2.31b |
| Total liabilities | CN¥6.98b |
| Total assets | CN¥9.29b |
Recent financial health updates
ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt
Oct 03
ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky
Jun 20These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively
Mar 04Recent updates
Even With A 32% Surge, Cautious Investors Are Not Rewarding ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) Performance Completely
Nov 09ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt
Oct 03A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb
Sep 06ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital
Jul 25ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely
Jun 21ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky
Jun 20These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively
Mar 04Financial Position Analysis
Short Term Liabilities: 301017's short term assets (CN¥5.3B) exceed its short term liabilities (CN¥5.3B).
Long Term Liabilities: 301017's short term assets (CN¥5.3B) exceed its long term liabilities (CN¥1.7B).
Debt to Equity History and Analysis
Debt Level: 301017's net debt to equity ratio (99.8%) is considered high.
Reducing Debt: 301017's debt to equity ratio has increased from 6.9% to 157.8% over the past 5 years.
Debt Coverage: 301017's debt is not well covered by operating cash flow (6.8%).
Interest Coverage: 301017's interest payments on its debt are not well covered by EBIT (0.7x coverage).